TNDM Tandem Diabetes Care, Inc.
Tandem Diabetes Care, Inc. (TNDM) is expected to report earnings on February 4, 2027, after the market close. The consensus earnings estimate is $0.08 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +6.1% since its last earnings release on November 5, 2026.
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About Tandem Diabetes Care, Inc.
Tandem Diabetes Care, Inc. is a medical device company engaged in the designing, development and commercialization of products for people with insulin-dependent diabetes. The Company’s flagship product is the t:slim Insulin Delivery System.
Sector
Healthcare
Industry
Medical Appliances/Equipment
Held By 2 ETFs, by dollar flow
Charts powered in part by Lightweight Charts™ by TradingView.